[Research Progress of Thalidomide and Its Derivatives in Treatment of Myelodysplastic Syndrome--Review].

Wang Yin, Jing-Wen; Jiang, Gao-Feng; Ni, Jian; Zhou, Yong-Ming

Wang Yin, Jing-Wen; Jiang, Gao-Feng; Ni, Jian; Zhou, Yong-Ming.

Afiliação

Wang Yin JW; Department of Hematology,Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430000, Hubei Province, China.
Jiang GF; Translational Medicine Center,Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430000, Hubei Province, China.
Ni J; Department of Onology Clinical Pharmacy, Brigham and Women's Hospital, Harvard Medical School, Boston MA02115, USA E-mail: Jni2@bwh.harvard.edu.
Zhou YM; Department of Hematology,Tianyou Hospital Affiliated to Wuhan University of Science and Technology, Wuhan 430000, Hubei Province, China E-mail: zhym112@126.com.

Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 29(6): 1967-1971, 2021 Dec.

Article em Zh | MEDLINE | ID: mdl-34893143

Assuntos

Síndromes Mielodisplásicas; Talidomida; Humanos; Agentes de Imunomodulação; Síndromes Mielodisplásicas/tratamento farmacológico; Talidomida/uso terapêutico

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Talidomida / Síndromes Mielodisplásicas Limite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google